Mental health outcomes in patients with moderate to severe psoriasis treated with bimekizumab: Analysis of phase 2/3 randomized trials

By sjmartinez • March 7, 2024

Blauvelt A, Armstrong A, Merola JF, Strober B, de Cuyper D, Peterson L, Davies O, Stark JL, Lebwohl M. Mental health outcomes in patients with moderate to severe psoriasis treated with bimekizumab: Analysis of phase 2/3 randomized trials. J Am Acad Dermatol. 2024 Mar 4:S0190-9622(24)00438-9. doi: 10.1016/j.jaad.2024.02.039. Epub ahead of print. PMID: 38447700.

Tags: bimekizumab, Clinical Trial, depression, Dermatology, long-term, mental health, plaque psoriasis, Publications, safety, suicidality, suicide

Facial Swelling in a Young Adult With Type 1 Diabetes: Morbihan Disease as a Scleroderma Mimic

Shammas R, Gudino-Rosales S, Kneiber D, Sarantopoulos GP, Aung T. Facial Swelling in a Young Adult With Type 1 Diabetes: Morbihan Disease as a Scleroderma[...]

Assessing workload, compensation, and burnout in academic dermatology: a national multi-institutional survey study

Brinks AL, Lawrence CN, Kearney CA, Maas D, Gillespie C, Adotama P, Senna M, Bordone L, Hordinsky M, Farah R, Aguh C, Mesinkovska N, Colavincenzo[...]

Whole genome sequence of the syntrophic fatty acid-degrading bacterium Syntrophomonas curvataGB8-1T

Humm E, Wofford NQ, Sieber JR, Morselli M, Pellegrini M, McInerney MJ, Ha SM, Gunsalus RP. Whole genome sequence of the syntrophic fatty acid-degrading bacterium Syntrophomonas[...]